Correlation Between Adagene and Champions Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Adagene and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adagene and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adagene and Champions Oncology, you can compare the effects of market volatilities on Adagene and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adagene with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adagene and Champions Oncology.

Diversification Opportunities for Adagene and Champions Oncology

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Adagene and Champions is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Adagene and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Adagene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adagene are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Adagene i.e., Adagene and Champions Oncology go up and down completely randomly.

Pair Corralation between Adagene and Champions Oncology

Given the investment horizon of 90 days Adagene is expected to under-perform the Champions Oncology. In addition to that, Adagene is 1.33 times more volatile than Champions Oncology. It trades about -0.01 of its total potential returns per unit of risk. Champions Oncology is currently generating about 0.08 per unit of volatility. If you would invest  607.00  in Champions Oncology on November 3, 2024 and sell it today you would earn a total of  492.00  from holding Champions Oncology or generate 81.05% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Adagene  vs.  Champions Oncology

 Performance 
       Timeline  
Adagene 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Adagene has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Champions Oncology 

Risk-Adjusted Performance

23 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Champions Oncology are ranked lower than 23 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating fundamental drivers, Champions Oncology reported solid returns over the last few months and may actually be approaching a breakup point.

Adagene and Champions Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Adagene and Champions Oncology

The main advantage of trading using opposite Adagene and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adagene position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.
The idea behind Adagene and Champions Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.